Key stats
About Portfolio Building Block World Pharma and Biotech Index ETF
Home page
Inception date
Nov 24, 2025
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Ordinary income
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Tidal Investments LLC
Distributor
Foreside Fund Services LLC
Identifiers
3
ISIN:US88635A2042
PBPH is passively managed, providing targeted exposure to pure-play companies in the pharmaceutical and/or biotechnology industries from the developed markets. The fund follows BITAs thematic methodology, selecting companies that derive at least 50% of their revenue from healthcare-related discovery, development, and therapeutics. Eligible securities must operate within one or more core healthcare sub-themes, including precision medicine & genetic diagnostics, pharmaceutical research & manufacturing, and biotechnology-based therapeutics. The portfolio typically holds 5080 constituents, weighted by free-float market capitalization. The index is reconstituted and rebalanced quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.76%
Health Technology99.43%
Finance0.33%
Bonds, Cash & Other0.24%
Cash0.24%
Stock breakdown by region
North America63.19%
Europe30.22%
Asia4.32%
Oceania1.51%
Middle East0.76%
Latin America0.00%
Africa0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
PBPH invests in stocks. The fund's major sectors are Health Technology, with 99.43% stocks, and Finance, with 0.33% of the basket. The assets are mostly located in the North America region.
PBPH top holdings are Eli Lilly and Company and Johnson & Johnson, occupying 15.72% and 8.98% of the portfolio correspondingly.
PBPH assets under management is 978.56 K USD. It's fallen 2.76% over the last month.
PBPH fund flows account for 0.00 USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, PBPH doesn't pay dividends to its holders.
PBPH shares are issued by Toroso Investments Topco LLC under the brand Portfolio Building Block. The ETF was launched on Nov 24, 2025, and its management style is Passive.
PBPH expense ratio is 0.13% meaning you'd have to pay 0.13% of your investment to help manage the fund.
PBPH follows the BITA Global Pharma and Biotech Select Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
PBPH invests in stocks.
PBPH trades at a premium (0.12%) meaning the ETF is trading at a higher price than the calculated NAV.